RosTrace

Tag: TranslationalMedicine

Robin Hayes

Experimental ALS Therapy Spurs Unprecedented Recoveries in Early Trials

In a remarkable departure from the typical expectations of neurodegenerative disease trials, an experimental therapy targeting a rare genetic form of amyotrophic lateral sclerosis (ALS) has yielded unprecedented functional recoveries in some patients. The therapeutic agent, ulefnersen—formerly known as jacifusen—was developed by Columbia University neurologist Dr. Neil Shneider in collaboration with Ionis Pharmaceuticals. Data published online in The Lancet reveal that two of the 12 patients treated for juvenile-onset FUS-mutant ALS experienced dramatic improvements, including the restoration of walking ability and respiratory independence, while another asymptomatic carrier has yet to develop disease signs after three years of continuous treatment.

· 5 min read

Sage Bennett

Snakebite Survivor’s Blood Powers Breakthrough in Universal Antivenom Research

Tim Friede, a former truck mechanic from Wisconsin, has spent the past 18 years doing what most people would consider unthinkable: injecting himself with venom from some of the world’s deadliest snakes. His goal was never fame or notoriety — it was to build immunity and, ultimately, save lives. Now, thanks to his extraordinary biological resilience, Friede has helped scientists develop one of the most promising antivenoms to date — a universal treatment that could drastically change how snakebites are managed globally.

· 5 min read

Ash Cooper

Optimizing mRNA Transfection in T-Cells: Sartorius Leverages High-Throughput Cytometry to Enhance Cancer Immunotherapy Outcomes

A new study sponsored by Sartorius, a global leader in biopharmaceutical innovation, has demonstrated promising advancements in optimizing mRNA transfection in human T-cells using high-throughput cytometry and live-cell imaging. By utilizing jetMESSENGER®, a non-viral mRNA transfection reagent, and leveraging state-of-the-art platforms like the Incucyte® Live-Cell Analysis System and iQue® High-Throughput Screening cytometer, Sartorius researchers have identified enhanced workflows that preserve T-cell viability, improve transfection efficiency, and amplify cytotoxic activity against cancer cells.

· 4 min read

Ash Cooper

Tailored Biopsies Significantly Improve Patient Outcomes, ROME Trial Finds

CHICAGO – A groundbreaking clinical trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 has demonstrated that patients with advanced solid tumors experience significantly improved survival outcomes when treatment is tailored using information from both tissue and liquid biopsies. The findings from the phase II, multicenter ROME trial could redefine the approach to precision oncology and patient care.

· 5 min read

Sage Bennett

Lab-Grown Teeth Edge Closer to Reality Thanks to Breakthrough Research

The prospect of lab-grown teeth might sound like the plot of a science fiction film, but scientists at King’s College London (KCL) and Imperial College London (ICL) have taken a critical step toward making it a clinical reality. In a major breakthrough announced on April 26, 2025, researchers unveiled a new hydrogel material that significantly enhances cell-to-cell communication, offering promising new methods to regenerate teeth naturally.

· 4 min read